Better Outcomes. Lower Cost. Family Support.

Lost productivity rivals medical costs

Undiagnosed genetic conditions are both a direct medical cost and productivity problem. Every year that a child’s actionable genetic condition goes undetected means more missed work, reduced on-the-job performance, and increased caregiver burden for a parent. GeneSprout helps families access appropriate care sooner, reducing their child’s diagnostic odyssey that drives medical costs, disease progression, caregiver burden, and avoidable productivity losses.

Real world evidence

The SAVES-Kids Health Economics study shows that genetic testing improves care and reduces healthcare costs by up to 61% in the year following testing for children with neurological conditions.

Pediatric diagnostic odyssey costs are avoidable

Early identification shortens the cycle of unnecessary tests and specialist visits, whose combined costs often exceed GeneSprout’s. A negative genetic result can also eliminate the need for further testing and provide peace of mind to families.

Detect a child is at increased risk for cancer before cancer appears

Research reported by Harvard suggests that genomic screening at birth could identify children at increased risk for certain childhood cancers, before symptoms appear, creating an opportunity for surveillance and early intervention.